Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. by Xie, O, Pollard, A, Mueller, J, Norheim, G

FetA antibodies induced by an outer membrane vesicle vaccine derived from a serogroup B meningococcal isolate with constitutive FetA expression by Sanders, H, Norheim, G, Chan, H, Dold, C, Vipond, C, Derrick, J, Pollard, A, Maiden, M, Feavers, I

Human B cell responses to dominant and sub-dominant antigens induced by a meningococcal outer membrane vesicle vaccine in a phase I trial by Rollier, CS, Dold, C, Marsay, L, Linder, A, Green, CA, Sadarangani, M, Norheim, G, Derrick, JP, Feavers, IM, Maiden, M, Pollard, AJ

Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based... by Norheim, G, Sadarangani, M, Omar, O, Yu, L, Mølbak, K, Howitz, M, Olcén, P, Haglund, M, van der Ende, A, Pollard, A

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies. by Xie, O, Bolgiano, B, Gao, F, Lockyer, K, Swann, C, Jones, C, Delrieu, I, Njanpop-Lafourcade, B, Tamekloe, T, Pollard, A, Norheim, G

Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: A population-based... by Norheim, G, Sadarangani, M, Omar, O, Yu, L, Mølbak, K, Howitz, M, Olcén, P, Haglund, M, Van Der Ende, A, Pollard, A

Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens. by Nagaputra, J, Rollier, C, Sadarangani, M, Hoe, J, Mehta, O, Norheim, G, Saleem, M, Chan, H, Derrick, J, Feavers, I, Pollard, A, Moxon, E

An OMV vaccine derived from a capsular group B meningococcus with constitutive FetA expression: preclinical evaluation of immunogenicity and toxicity by Norheim, G, Sanders, H, Mellesdal, J, Sundfør, I, Chan, H, Brehony, C, Vipond, C, Dold, C, Care, R, Saleem, M, Maiden, M, Derrick, J, Feavers, I, Pollard, A

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial. by Marsay, L, Dold, C, Green, C, Rollier, C, Norheim, G, Sadarangani, M, Shanyinde, M, Brehony, C, Thompson, A, Sanders, H, Chan, H, Haworth, K, Derrick, J, Feavers, I, Maiden, M, Pollard, A

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on neisseria meningitidis recombinant porA protein: a comparison in mice by Mehta, O, Norheim, G, Hoe, J, Rollier, C, Nagaputra, J, Makepeace, K, Saleem, M, Chan, H, Ferguson, D, Jones, C, Sadarangani, M, Hood, D, Feavers, I, Derrick, J, Pollard, A, Moxon, E

Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007 by Norheim, G, Mueller, JE, Njanpop-Lafourcade, B-M, Delrieu, I, Findlow, H, Borrow, R, Xie, O, Nagaputra, J, Ramasamy, R, Dold, C, Tamekloe, TA, Rollier, CS, Watt, H, Kere, AB, Næss, LM, Pollard, AJ

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. by Micoli, F, Romano, MR, Tontini, M, Cappelletti, E, Gavini, M, Proietti, D, Rondini, S, Swennen, E, Santini, L, Filippini, S, Balocchi, C, Adamo, R, Pluschke, G, Norheim, G, Pollard, A, Saul, A, Rappuoli, R, MacLennan, C, Berti, F, Costantino, P

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebol... by Henao-Restrepo, A, Camacho, A, Longini, I, Watson, C, Edmunds, W, Egger, M, Carroll, M, Dean, N, Diatta, I, Doumbia, M, Draguez, B, Duraffour, S, Enwere, G, Grais, R, Gunther, S, Gsell, P, Hossmann, S, Watle, S, Kondé, M, Kéïta, S, Kone, S, Kuisma, E, Levine, M, Mandal, S, Mauget, T, Norheim, G, Riveros, X, Soumah, A, Trelle, S, Vicari, A, Røttingen, J, Kieny, M